• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉取出心脏移植术后置入的起搏导线

Transvenous Extraction and Removal of Pacing Leads Placed after Cardiac Transplantation.

作者信息

Norton Caleb, Holmes Benjamin, Al Aboud Asad, Kim Eun-Jeong, Gonzales Holly, Ellis Christopher, John Roy, Crossley George H, Montgomery Jay

机构信息

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Case Rep Cardiol. 2019 Jan 3;2019:6270950. doi: 10.1155/2019/6270950. eCollection 2019.

DOI:10.1155/2019/6270950
PMID:30719356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6335660/
Abstract

There is an increasing prevalence of cardiac implantable electronic devices (CIEDs) due to expanding adoption and availability of these evidence-based therapies. With the increased prevalence of these life-saving devices, there has also been an increased demand for lead removal and lead extraction. Understanding the specific subgroups of patients at high risk for complications during and after lead extraction has become imperative to properly manage endovascular CIED leads. There have been multiple published studies describing clinical variables that predict adverse outcomes in CIED system extractions; however, the risk of complications in leads placed after cardiac transplantation has not specifically been addressed to date. We present four cases of transvenous extraction and removal of pacing leads placed after cardiac transplantation. There were no major complications related to extraction in these four cases; however, three of the four patients died within one year after the procedure. While the etiology of death in these cases seemed to be unrelated to the extraction procedure, the indications for extraction (infection in the setting of immunosuppression and calcineurin-associated ESRD and poor sensing/capture possibly secondary to chronic rejection and/or frequent right heart biopsies) likely contributed at least indirectly to the subsequent death.

摘要

由于这些循证疗法的应用范围不断扩大且可及性提高,心脏植入式电子设备(CIED)的患病率日益上升。随着这些救生设备的患病率增加,对导线移除和拔除的需求也有所增加。了解在导线拔除期间及之后发生并发症的高风险患者的特定亚组,对于妥善管理血管内CIED导线至关重要。已有多项发表的研究描述了预测CIED系统拔除不良结局的临床变量;然而,心脏移植后植入导线的并发症风险迄今尚未得到专门探讨。我们报告了4例心脏移植后经静脉拔除起搏导线的病例。这4例病例中均未发生与拔除相关的重大并发症;然而,4例患者中有3例在术后1年内死亡。虽然这些病例的死亡原因似乎与拔除手术无关,但拔除的指征(免疫抑制和钙调神经磷酸酶相关的终末期肾病背景下的感染,以及可能继发于慢性排斥反应和/或频繁右心活检的感知/夺获不良)可能至少间接导致了随后的死亡。

相似文献

1
Transvenous Extraction and Removal of Pacing Leads Placed after Cardiac Transplantation.经静脉取出心脏移植术后置入的起搏导线
Case Rep Cardiol. 2019 Jan 3;2019:6270950. doi: 10.1155/2019/6270950. eCollection 2019.
2
Transvenous removal of cardiac implantable electronic device leads.经静脉取出心脏植入式电子设备导线
Rev Port Cardiol. 2015 Dec;34(12):739-44. doi: 10.1016/j.repc.2015.07.008. Epub 2015 Nov 18.
3
Clinical Outcomes of Patients with HIV Undergoing Lead Extraction for Infectious and Noninfectious Indications.因感染性和非感染性指征接受导线拔除术的HIV患者的临床结局
Pacing Clin Electrophysiol. 2016 Feb;39(2):122-7. doi: 10.1111/pace.12773. Epub 2015 Nov 27.
4
Anesthetic Management of Laser Lead Extraction for Cardiovascular Implantable Electronic Devices.心血管植入式电子设备激光导线拔除术的麻醉管理
Semin Cardiothorac Vasc Anesth. 2017 Dec;21(4):302-311. doi: 10.1177/1089253217728581. Epub 2017 Sep 21.
5
Comparison of standard and modified transvenous techniques for complex pacemaker lead extractions in the context of cardiac implantable electronic device-related infections: a 10-year experience.在心脏植入式电子设备相关感染的情况下,比较标准和改良的经静脉技术用于复杂起搏器导线拔除:一项 10 年经验。
Europace. 2013 Nov;15(11):1629-35. doi: 10.1093/europace/eut077. Epub 2013 Jul 25.
6
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
7
Transvenous Lead Extractions: Current Approaches and Future Trends.经静脉导线拔除:当前方法与未来趋势。
Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2.
8
Incidence and Predictors of Perioperative Complications With Transvenous Lead Extractions: Real-World Experience With National Cardiovascular Data Registry.经静脉导线拔除术围手术期并发症的发生率及预测因素:国家心血管数据注册中心的真实世界经验。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e004768. doi: 10.1161/CIRCEP.116.004768. Epub 2018 Feb 16.
9
Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.经静脉导线拔除术后 30 天和 1 年死亡率的预测因素:单中心经验。
Europace. 2014 Aug;16(8):1218-25. doi: 10.1093/europace/eut410. Epub 2014 Feb 25.
10
Overcoming the current issues surrounding device leads: reducing the complications during extraction.克服当前围绕设备导线的问题:减少拔除过程中的并发症。
Expert Rev Med Devices. 2017 Jun;14(6):469-480. doi: 10.1080/17434440.2017.1332990.

引用本文的文献

1
Long-Term Outcomes of Permanent Pacemaker Implantation in Bicaval Heart Transplant Recipients.双腔心移植受者中永久性起搏器植入的长期结果。
JACC Clin Electrophysiol. 2023 Sep;9(9):1964-1971. doi: 10.1016/j.jacep.2023.05.020. Epub 2023 Jul 19.

本文引用的文献

1
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.2017年心律学会心血管植入式电子装置导线管理与拔除专家共识声明
Heart Rhythm. 2017 Dec;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001. Epub 2017 Sep 15.
2
Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction.经静脉起搏器和除颤器导线拔除术后30天全因死亡率预测列线图。
Heart Rhythm. 2015 Dec;12(12):2381-6. doi: 10.1016/j.hrthm.2015.07.024. Epub 2015 Jul 17.
3
Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction.经静脉植入式心脏复律除颤器导线拔除术中纤维性黏连的主要预测因素。
Heart Rhythm. 2014 Dec;11(12):2196-201. doi: 10.1016/j.hrthm.2014.08.011. Epub 2014 Aug 8.
4
Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.心脏植入式电子设备感染患者行经静脉导线拔除术 1 年死亡率的危险因素:感染类型和是否存在赘生物对生存的影响。
Europace. 2014 Oct;16(10):1490-5. doi: 10.1093/europace/euu147. Epub 2014 Aug 2.
5
Multicenter experience with extraction of the Riata/Riata ST ICD lead.Riata/Riata ST植入式心脏复律除颤器导线拔除的多中心经验
Heart Rhythm. 2014 Sep;11(9):1613-8. doi: 10.1016/j.hrthm.2014.05.014. Epub 2014 May 20.
6
Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.在超过 5000 例慢性血管内起搏器和除颤器导联拔除的经验中,预测患者不良结局的临床因素。
Heart Rhythm. 2014 May;11(5):799-805. doi: 10.1016/j.hrthm.2014.01.016. Epub 2014 Jan 17.
7
Frequency of superior vena cava obstruction in pediatric heart transplant recipients and its relation to previous superior cavopulmonary anastomosis.儿童心脏移植受者上腔静脉阻塞的频率及其与先前上腔静脉-肺动脉吻合术的关系。
Am J Cardiol. 2013 Jul 15;112(2):286-91. doi: 10.1016/j.amjcard.2013.03.029. Epub 2013 Apr 12.
8
Long-term mortality after transvenous lead extraction.经静脉导线拔除后的长期死亡率。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):252-7. doi: 10.1161/CIRCEP.111.965277. Epub 2012 Feb 23.
9
Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database.心脏移植后需要起搏器治疗的缓慢性心律失常的长期结果和临床预测因素:分析 UNOS/OPTN 心脏移植数据库。
Heart Rhythm. 2010 Nov;7(11):1567-71. doi: 10.1016/j.hrthm.2010.06.026. Epub 2010 Jun 22.
10
Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead.多中心应用 Sprint Fidelis 植入式心脏复律除颤器导线取出的经验。
J Am Coll Cardiol. 2010 Aug 17;56(8):646-50. doi: 10.1016/j.jacc.2010.03.058. Epub 2010 Jul 2.